Fat Freezing — What It Does and Does Not Do

Fat freezing is a contouring tool, not a weight-loss treatment. Cryolipolysis reduces the thickness of a discrete subcutaneous pocket and does nothing else — it does not reduce body weight meaningfully, it does not reach visceral fat, and it does not tighten the skin that sits above the fat it removes.

The Mechanism, Stated Precisely

Adipocytes are more sensitive to cold injury than the skin, nerves and vessels around them. Lipid within the fat cell crystallises at temperatures the surrounding tissues tolerate without damage, and that crystallisation triggers a slow inflammatory cascade ending in apoptosis — programmed cell death rather than rupture. The distinction matters, because apoptosis releases cell contents gradually into the macrophage clearance pathway rather than dumping lipid into the tissue at once.

A cryolipolysis applicator draws the target tissue into a cup and holds it at a controlled sub-zero temperature for a set interval. The pocket must be pinchable for the applicator to acquire it, which is the first and most important selection criterion — fat that cannot be drawn into the cup cannot be treated by this mechanism at all.

Clearance then takes time. Macrophages infiltrate the treated area over the following weeks, phagocytose the apoptotic adipocytes, and the lipid is processed through normal metabolic pathways. Visible change begins around six weeks and continues to approximately twelve. Nothing happens on the day, and a patient expecting an immediate difference has been told the wrong thing about what was done.

What It Is Genuinely Good At

The ideal indication is a discrete, pinchable, well-demarcated subcutaneous pocket in a patient whose weight is stable and who is not seeking weight reduction. Flanks, lower abdomen, inner thigh, bra line, and the submental pocket under the chin all fit that description when the anatomy is right. These are the sites where a contour irregularity persists despite diet and training, and where removing a layer of fat changes the silhouette.

In that setting, the effect is real and measurable — a reduction in the thickness of the treated fat layer, visible as a smoother line rather than as a smaller number on a scale. Patients who understand they are buying a contour change rather than a size change are consistently the ones who are satisfied with it.

The selection process is therefore the entire treatment. Stubborn fat pockets that are genuinely localised respond. Diffuse subcutaneous fat across a broad region does not respond in a way that reads visually, because reducing a thick layer by a fraction across a large area changes the contour very little. The pinch test at the consultation settles which is which.

What It Is Not

It is not weight loss. The mass of tissue removed in a single applicator cycle is small, and the change on a scale is negligible. A patient with a raised BMI seeking fat freezing in place of weight reduction is being offered the wrong intervention, and a practice that accepts that booking without saying so is not being straight.

It does not reach visceral fat. Cryolipolysis acts only on what can be drawn into the applicator, which by definition is subcutaneous. Abdominal fullness driven by intra-abdominal fat — firm, non-pinchable, worse on exhalation — is a metabolic finding and belongs in a discussion about diet, exercise and, where appropriate, medical management. It is not a contouring problem.

It does not tighten skin. Cold injury to adipocytes does not produce meaningful dermal collagen contraction, and removing volume from beneath loose skin can make the looseness more apparent rather than less. Where skin laxity is part of the presentation, that needs grading in its own right before any fat reduction is planned — the reasoning is set out in laxity or excess.

Paradoxical Adipose Hyperplasia

The uncommon complication that deserves naming is paradoxical adipose hyperplasia. Rather than reducing, the treated area enlarges — typically some months after treatment, forming a firm, well-demarcated mass conforming closely to the shape of the applicator that was used. It is painless, it does not resolve spontaneously, and it does not respond to further cryolipolysis.

It is rare. It is also real, it is documented across devices and operators, and its cause is not fully understood — proposed mechanisms include a hypoxia-driven preadipocyte response rather than simple failure of apoptosis. It appears to occur more often in men and in certain anatomical sites, though the reported associations are not strong enough to exclude anyone on that basis.

The correct handling is to state it before treatment rather than after. A patient who knows this is possible, knows how it presents, and knows that the correction is surgical is a patient who can consent properly. A patient told only about numbness and bruising has not been given the information they needed. Consent that omits the uncomfortable item is not consent.

The Ordinary Side Effects

Immediately after the applicator is removed, the treated tissue is firm, blanched and cold, and it is massaged to break up the crystallised tissue. Over the following days most patients experience swelling, altered sensation and tenderness. Bruising is common where suction was used. None of this is unexpected and none of it requires intervention.

Numbness over the treated area is the most consistent finding, and it can last for several weeks. Occasionally patients report a delayed neuropathic pain beginning some days after treatment — sharp, intermittent, and settling over one to three weeks. It is self-limiting but it is alarming if nobody mentioned it in advance.

What is not normal is progressive enlargement, a firm discrete mass appearing weeks or months later, or skin changes over the treated area. Those warrant review rather than a second cycle. The instruction given at discharge should include what to report, not only what to expect.

Where Other Modalities Fit Better

Cryolipolysis is one modality among several, and it is not the right one in every presentation. Where the fat is diffuse rather than pinchable, or where skin laxity accompanies it, microwave-based approaches such as Onda Pro deliver energy differently and address both the adipose layer and the overlying dermis rather than one of the two.

Where the deficit is muscular rather than adipose — a soft abdominal contour in a lean patient, or a flat gluteal profile — reducing fat is the wrong target entirely. Electromagnetic muscle stimulation such as Z-Sculpt builds the underlying structure, and the contour improves because the frame beneath the skin changed, not because tissue was removed.

Most body presentations are mixed, which is why the assessment precedes the device selection rather than following it. A body contouring plan that names which layer is being addressed at each stage is a plan. A plan built around a single machine applied to whatever walks in is a schedule.

Realistic Expectations And Maintenance

A single cycle over a given area produces a partial reduction in the fat layer, not its removal. Additional cycles at appropriate intervals produce further reduction, with diminishing returns as the remaining layer thins. Patients should be told the expected number of cycles at the outset rather than discovering it incrementally.

The adipocytes destroyed do not return. This is often presented as permanence, and it is accurate only in a narrow sense — the remaining fat cells in the treated area and everywhere else retain their full capacity to enlarge. Weight gain after treatment will change the contour again. The result is durable in a weight-stable patient and not otherwise, and saying so is part of the consultation rather than a caveat added afterwards.

Photography at standardised distance and lighting before the first cycle is worth insisting on, because the change is gradual, occurs over three months, and is genuinely difficult to judge from memory. Patients who assess their own result against a recollection rather than an image very often underestimate what happened.